Can anti-rheumatic treatments deliver cardiovascular protection?

People with rheumatoid arthritis have increased arterial inflammation that is responsive to effective treatments Introduction Rheumatoid arthritis is a chronic inflammatory disease that mainly affects a person’s joints, causing pain and disability among other symptoms. Rheumatoid arthritis can affect people of all ages, but it most often starts between the ages of 40 and 60. […]

Read More…

Window of opportunity for managing fatigue

Many but not all people with rheumatoid arthritis achieve sustained fatigue improvement with intensive drug therapy, but early and effective treatment could mitigate this. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that mainly affects a person’s joints, causing pain and disability among other symptoms. Rheumatoid arthritis can affect people of all ages, but it […]

Read More…

Barriers to fulfilling patient education recommendations

Common barriers to providing recommended patient education are lack of time or training. INTRODUCTION Inflammatory arthritis is a group of diseases including spondyloarthritis, rheumatoid arthritis, and psoriatic arthritis. These are chronic inflammatory diseases that affects a person’s joints, and may cause pain and disability. Patient education is a planned interactive learning process designed to support […]

Read More…

Updated: Managing RA

This is the lay version of the EULAR recommendations for the management of rheumatoid arthritis using synthetic and biologic disease-modifying antirheumatic drugs. The original publication can be downloaded from the EULAR website: www.eular.org. Smolen JS, Landewé RBM, Bergstra SA, et alEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: […]

Read More…

Inflammation correlates with PROs in early RA

In the early phases inflammatory variables directly correlate with the PGA across different disease activity states INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, and may cause pain and disability. Rheumatoid arthritis can affect people of all ages, but it most often starts between the ages of 40 and 60. […]

Read More…

New: EULAR Points to consider for remote care in RMDs

This is the lay version of the EULAR points to consider for remote care in people with rheumatic and musculoskeletal diseases. The original publication can be downloaded from the EULAR website: www.eular.org. De Thurah A, Bosch P, Marques A, et al2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases Annals of […]

Read More…

Favourable balance of benefit and harm for prednisolone in older RA patients

Add-on low-dose prednisolone has beneficial long-term effects in seniors with established rheumatoid arthritis INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, and may cause pain and disability. Rheumatoid arthritis can affect people of all ages, but it most often starts between the ages of 40 and 60. Rheumatoid arthritis is […]

Read More…

High steroid-free success rates after glucocorticoid bridging

90% of people with early rheumatoid arthritis are steroid-free 2 years after bridging therapy INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, and may cause pain and disability. Rheumatoid arthritis can affect people of all ages, but it most often starts between the ages of 40 and 60. Rheumatoid arthritis […]

Read More…

Fully vaccinated people with systemic rheumatic diseases have less severe COVID outcomes

Breakthrough COVID-19 had lower hospitalisation and mortality in vaccinated patients INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19 has forced people to change their behaviours to try to limit […]

Read More…

Comparison of heart attack risk across biologic DMARDs

The risk of acute coronary syndrome varies little across individual bDMARDs in people with rheumatoid arthritis INTRODUCTION Rheumatoid arthritis (shortened to RA) is a chronic inflammatory disease that affects a person’s joints, and may cause pain and disability. RA can affect people of all ages, but the risk increases with age. RA is more common […]

Read More…